Most of NFL Brain Trauma Research Donation to NIH to Go Unspent

The football league and the government agency part ways over how the money should be used.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

man looks at brain scan images on computerU.S. AIR FORCE/SENIOR AIRMAN JULIANNE SHOWALTERFollowing the release of a study earlier this week that found chronic traumatic encephalopathy in 110 out of 111 former National Football League (NFL) players, the National Institutes of Health (NIH) has announced it will allow a funding agreement with the league to lapse with more than half of the money unspent.

ESPN reports that nearly five years ago, the NFL made a $30 million donation to the NIH for research on the relationship between brain disease and playing football. But the relationship between the two has been fraught; according to a congressional report released last year, the “NFL did not carry out its commitment to respect the science and prioritize health and safety,” but instead “improperly attempted to influence the grant selection process at NIH.”

In particular, the NFL, which had veto power over the grants resulting from its donation, objected to a major award to a group led by Boston University neuroscientist Robert Stern, ESPN reports. That left NIH to try to cover much of the grant with other funds.

With the funding agreement about ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Shawna Williams

    Shawna was an editor at The Scientist from 2017 through 2022. She holds a bachelor's degree in biochemistry from Colorado College and a graduate certificate and science communication from the University of California, Santa Cruz.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo